These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Hypoglycemic effects of 1-butyl-3-p-toluene sulfonylurea given orally in human diabetic subjects; a preliminary report. MILLER M; CRAIG JW Metabolism; 1956 Mar; 5(2):162-4. PubMed ID: 13296878 [No Abstract] [Full Text] [Related]
5. Relation to quantity of sulfonylurea by mouth to the hypoglycemic response in normal human subjects. DIENGOTT D; MIRSKY IA J Pharmacol Exp Ther; 1956 Oct; 118(2):168-73. PubMed ID: 13368054 [No Abstract] [Full Text] [Related]
6. The action of a sulfonylurea hypoglycemic agent (orinase) in extrahepatic tissues. BRITTON B; GRABOWSKI R; WICK AN Metabolism; 1956 Nov; 5(6 Part 2):739-43. PubMed ID: 13378041 [No Abstract] [Full Text] [Related]
7. Intrapancreatic perfusion of the antidiabetic sulfonylureas. COLWELL AR; COLWELL AR; COLWELL JA Metabolism; 1956 Nov; 5(6 Part 2):749-56. PubMed ID: 13378043 [No Abstract] [Full Text] [Related]
8. Hypoglycemic action of orinase, effect on output of glucose by liver. ANDERSON GE; PERFETTO AJ; TERMINE CM; MONACO RR Proc Soc Exp Biol Med; 1956 Jun; 92(2):340-5. PubMed ID: 13350341 [No Abstract] [Full Text] [Related]
9. Hypoglycemic sulfonylureas in various types of experimental diabetes. BUSE JF; GORDON MF; LUKENS FD Diabetes; 1957; 6(1):7-12; discussion, 19-20. PubMed ID: 13397410 [No Abstract] [Full Text] [Related]
10. [Hypoglycemic action of sulfonamide compounds]. BUTTURINI U G Clin Med; 1956 Sep; 37(9):1217-48. PubMed ID: 13384740 [No Abstract] [Full Text] [Related]
11. Hypoglycemic actions of tolbutamide and carbutamide. TUCKER BW; WILLIAMS RH Metabolism; 1956 Nov; 5(6 Part 2):801-6. PubMed ID: 13378049 [No Abstract] [Full Text] [Related]
12. [The effect of a new antidiabetic sulfonamide on the intestinal flora]. MEHNERT H Klin Wochenschr; 1956 Jun; 34(23-24):644-5. PubMed ID: 13347031 [No Abstract] [Full Text] [Related]
13. Studies on the actions of oral hypoglycemic compounds. COX RW; WILLIAMS RH Diabetes; 1957; 6(3):270-3. PubMed ID: 13427634 [No Abstract] [Full Text] [Related]
14. [Problem of the influence of the antidiabetic D 680 on A cells of the islands of Langerhans]. SCHMID R; BLOBEL R Endokrinologie; 1957; 34(3):155-61. PubMed ID: 13427717 [No Abstract] [Full Text] [Related]
15. [Clinical applications of hypoglycemic and antidiabetic drugs]. LANDABURE PB Dia Med; 1956 Jun; 28(40):1100-6. PubMed ID: 13344290 [No Abstract] [Full Text] [Related]
16. [Practical indications for treatment of diabetes mellitus by hypoglycemic sulfamides administered orally]. RAVINA A; PESTEL Bull Mem Soc Med Hop Paris; 1956; 72(16-18):535-8. PubMed ID: 13342957 [No Abstract] [Full Text] [Related]
17. [Morphological changes of the pancreatic islets and their relations to carbohydrate metabolism; with special reference to peroral antidiabetic drugs]. CREUTZFELDT W Wien Z Inn Med; 1956 Jun; 37(6):217-30. PubMed ID: 13353187 [No Abstract] [Full Text] [Related]